Log In
BCIQ
Print this Print this
 

Allocol

  Manage Alerts
Collapse Summary General Information
Company Sigmoid Pharma Ltd.
DescriptionCyclosporine combination
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase I
Standard IndicationGraft-versus-host disease (GvHD)
Indication DetailsTreat Graft-versus-host disease (GvHD)
Regulatory Designation U.S. - Orphan Drug (Treat Graft-versus-host disease (GvHD))
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today